I am a Biomedical Scientist at the University of British Columbia (UBC) with over eight years of experience specializing in molecular oncology and host-pathogen interactions. My research is dedicated to understanding the intersection of genetic stability and tissue morphogenesis, with a particular focus on how BRCA1 deficiency impacts mammary gland development and long-term health.

I specialize in developing high-fidelity 3D organoid models and Genetically Engineered Mouse Models (GEMMs) to validate therapeutic targets. By integrating complex viral delivery systems—including Lentiviral and Adenoviral vectors—with multi-omic datasets, I work to uncover the fundamental mechanisms that drive neoplastic transformation.

Throughout my career, I have focused on translating mechanistic biological insights into scalable preclinical platforms. I am passionate about advancing our understanding of how structural defects in mammary differentiation may precede disease, ultimately aiming to bridge the gap between fundamental molecular research and clinical applications in women’s health.